In Mayo Collaborative Services v. Prometheus Laboratories, Inc., decided March 20, 2012, the Supreme Court ruled unanimously that the claimed methods for optimizing the dosage of medication based on a body's reaction to the drug were unpatentable under section 101 of the Patent Act. In particular, the Court ruled that the patent claims covered “natural phenomena,” which cannot be patented because they are the fundamental building blocks of science. Seminar Date:
March 27, 2012
|
Online Materials LES Member Price:$0.00 Non-Member Price:$0.00 |